Count on Cortiva® allograft dermis for predictable graft performance
Cortiva®® allograft dermis is a non-crosslinked acellular dermal matrix (ADM). It is a safe and natural biologic option for the repair, replacement, reconstruction, or augmentation of soft tissues including plastic and reconstructive surgery procedures.1

With precise tolerances for allograft thickness and size,1 Cortiva® allograft dermis delivers exceptional handling predictability that you can depend on every time you open the package.

Cortiva® allograft dermis, processed using a proprietary method that maintains the native dermal structure, has demonstrated rapid revascularization and remodeling to support graft incorporation.1,2,3,4,*,†

Maintaining the highest standards of quality, from donor screening to terminal sterilization, Cortiva® allograft dermis provides surgeons with an ADM they can depend on for a consistent and excellent graft experience.1

Discover why Cortiva® allograft dermis stands above the rest

Evergen is a leading provider of tissue-based implants with a commitment to scientific integrity, safety, and quality. New technologies and surgeon engagement allow for the processing of reliable, high-performing implants that ultimately enhance patients' lives and our healthcare partners' experience. By choosing Evergen as your trusted implant provider, you prioritize quality above all else.

Portfolio at a glance

Proven commitment to quality

Precise thickness consistency of +/- 0.1 - 0.125mm.1
Measurements are taken every 2cm to ensure thickness consistency across the entire graft.1
Graft length and width are confirmed twice using a laser-calibrated ruler.1
All grafts conform to specifications without deviation. Graft measurements are not averaged.
« SCROLL »

Coordinate implant ordering with your local representative:

800-624-7238

customerservice@evergenbio.com
References
  1. Data on file at Evergen.
  2. Moyer, et. al. 2017. "A histological comparison of two human acellular dermal matrix products in prosthetic-based breast reconstruction." Plastic and Reconstructive Surgery Global Open, December 2017, 5(12).
  3. Keane AM, et al. "Cortiva vs AlloDerm in Prepectoral and Partial Submuscular Implant-Based Breast Reconstruction: A Randomized Clinical Trial." Plast Reconstr Surg. 2023 Dec 12.
  4. Gierek M, et al. "Human Acellular Dermal Matrix in  Reconstructive Surgery-A Review." Biomedicines. 2022 Nov 9;10(11):2870.
* Performance data from animal models may not be representative of performance in humans.
† Clinical cases are unique and individual results may vary.
DESCRIPTION
Cortiva® 1mm, Cortiva® 1mm Tailored, Cortiva® 1mm Perforated, and Cortiva Silhouette® allograft dermis are dehydrated dermis from donated human tissue processed through the Tutoplast® tissue sterilization process. The implants are preserved by the Tutoplast® tissue sterilization process which retains the three-dimensional collagen structure responsible for the multidirectional, mechanical properties of the original dermal tissue. These implants are regulated as 361 human cell and tissue product (HCT/Ps) as defined in US FDA 21 CFR 1271 and are restricted to homologous use for the repair, replacement, reconstruction or augmentation of soft tissue by a qualified healthcare professional (e.g., physician). These implants are provided sterile and require rehydration prior to use.
WARNINGS
CORTIVA SILHOUETTE, CORTIVA 1MM PERFORATED, CORTIVA 1MM: The same potential medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. The surgeon is responsible for informing the patient of the risks associated with their treatment and the possibility of complications or adverse reactions. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. Resorption of the implant and commensurate substitution with functional host tissue is required to restore function. CORTIVA SILHOUETTE: Do not use the implant for abdominal wall repair, hernia repair or for other procedures that require substantial tensile strength. The implant should be used only where it is under minor to moderate tension. CORTIVA 1MM PERFORATED: Do not use the implant for abdominal wall repair, hernia repair or for other procedures that require substantial tensile strength. The implant should be used only where it is under minor to moderate tension. Do not further perforate the implant. Additional perforations may affect implant performance. CORTIVA 1MM TAILORED: The same medical/surgical conditions or complications that apply to any surgical procedure may occur during or following implantation. The surgeon is responsible for informing the patient of the risks associated with their treatment and the possibility of complications or adverse reactions. As with any human tissue implant, the potential for transmission of infectious agents may exist. A small number of patients may experience localized immunological reactions to the implant. Successful treatment is dependent upon the patient’s host tissue response. Resorption of the implant and commensurate substitution with functional host tissue is required to restore function.
PRECAUTIONS
Prior to use, the surgeon must become familiar with the implant and the surgical procedure. Poor general medical condition or any pathology that would limit the blood supply and compromise healing should be considered when selecting patients for procedures using this implant; as such conditions may compromise outcomes. The implant should be used with caution in surgical sites where an active infection is present or in sites with poor perfusion. If the surgeon determines that the clinical circumstances require implantation in a site that is contaminated or infected, appropriate local and/or systemic anti-infective measures should be taken. Appropriate placement and fixation of the implant are critical to the success of the surgical procedure.
All Cortiva® and Cortiva Silhouette® allograft dermis implants are processed by RTI Surgical, Inc. (Alachua, FL).

Please refer to the labeling for complete instructions for use.
Regulatory approvals vary by country. Therefore, we kindly ask you to contact the distributor in your region regarding availability of specific products in your region.

® indicates U.S. trademark registration. All trademarks and/or images are the property of their respective owners or holders.
© Evergen 2025 / RTI Surgical, Cook BioTech and Collagen Solutions are now Evergen. All rights reserved.
‍
Distributed by:
Evergen
11621 Research Circle
Alachua, FL 32615 USA
T 877.343.6832
evergenbio.com